Document is current
Any future updates will be listed below
-
Authors
Desgrouas, Maxime https://orcid.org/0000-0002-7713-2293
Demiselle, Julien https://orcid.org/0000-0002-7255-1114
Stiel, Laure
Brunot, Vincent
Marnai, Rémy
Sarfati, Sacha
Fiancette, Maud
Lambiotte, Fabien
Thille, Arnaud W.
Leloup, Maxime
Clerc, Sébastien
Beuret, Pascal
Bourion, Anne-Astrid
Daum, Johan
Malhomme, Rémi
Ravan, Ramin
Sauneuf, Bertrand
Rigaud, Jean-Philippe
Dequin, Pierre-François
Boulain, Thierry https://orcid.org/0000-0003-4664-3661
- License Information
-
More Information
Article History
Received: 11 March 2023
Accepted: 24 May 2023
First Online: 17 June 2023
Declarations
:
: This study was approved by the French Intensive Care Society Ethical Committee number CE SRLF 21–67.
: Not Applicable.
: AWT declares payments for lectures and travel expense coverage to attend scientific meetings from Fisher&Paykel, GE Healthcare and Sedana Medical. JPR declares fees from PANACEA—Paris for lectures. PFD has received payment from Aridis Pharmaceuticals for consulting work, and is leading a clinical trial co-funded by Fisher & Paykel Healthcare and Aerogen. All other authors declare that they have no competing interests.
